AuraSense, LLC

8045 Lamon Avenue Suite 410
Skokie, IL 60077
http://www.aurasense.com
20 Employees

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.88MM
First Award Date 07/22/10
Most Recent Award Date 03/15/13

Key Personnel

Last Name Name Awards Contact
Giljohann David Giljohann 3 Message
Daniel Weston Daniel 2 Message
Crocker Percy Van Crocker 2 Message

5 Awards Won

Phase 2 STTR

Institution: Northwestern University

Agency: Air Force
Topic: AF10-BT24
Budget: 03/15/13 - 03/14/15

ABSTRACT: Mycotoxins are toxic secondary metabolites of molds and fungi, many of which are pathogenic to humans. In general, mycotoxins enter the body through the skin, digestive tract, or through respiration. Exposure to a few milligrams can be lethal. Mycotoxins have a high likelihood of being weaponized, due to their ease of large scale produ...

Phase 2 SBIR

Agency: Air Force
Topic: AF103-043
Budget: 07/25/12 - 10/24/14

ABSTRACT: AuraSense is developing and commercializing NanoFlare technology as an enabling tool for detecting RNA levels in cells. Current methods for sensing of viral exposure require great amounts of virus particles to be present in blood, or extensive processing of blood to isolate virus-specific genomic markers. We will develop NanoFlare se...

Phase 1 STTR

Institution: Northwestern University

Agency: Air Force
Topic: AF10-BT24
Budget: 09/01/11 - 05/31/12

ABSTRACT: Mycotoxins are a class of weaponizable toxic secondary metabolites of molds and fungi. No treatments exist for exposure to these lipophilic poisons. AuraSense proposes to use lipid and protein modified gold nanoparticles to develop constructs for the sequestration of toxic lipophilic molecules. Nanoparticles are ideal materials for dev...

Phase 1 SBIR

Agency: Air Force
Topic: AF103-043
Budget: 04/04/11 - 02/04/12

ABSTRACT: Polyvalent nanoparticle constructs have unique properties that make them ideal for gene regulation applications, while overcoming many of the challenges which have prevented oligonucleotides from being developed into viable therapies. Specifically, AuraSense is developing constructs which are highly resistant to nuclease digestion, ha...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-189
Budget: 07/22/10 - 07/21/11

DESCRIPTION (provided by applicant): Under the auspices of this small business innovation research (SBIR) grant, AuraSense LLC will develop a novel nanotechnology, "Nano-flares", for the detection of low abundance microRNA (miR) species in living cells in real-time. MicroRNAs are short (~22 nucleotides in length) non-protein coding RNA sequences...